Dianthus Therapeutics, Inc. /DE/ Quarterly Depreciation in USD from Q3 2022 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly/annual Depreciation history and growth rate from Q3 2022 to Q4 2024.
  • Dianthus Therapeutics, Inc. /DE/ Depreciation for the quarter ending December 31, 2024 was $26K, a 36.8% increase year-over-year.
  • Dianthus Therapeutics, Inc. /DE/ Depreciation for the twelve months ending December 31, 2024 was $96K, a 43.3% increase year-over-year.
  • Dianthus Therapeutics, Inc. /DE/ annual Depreciation for 2024 was $96K, a 43.3% increase from 2023.
  • Dianthus Therapeutics, Inc. /DE/ annual Depreciation for 2023 was $67K, a 123% increase from 2022.
  • Dianthus Therapeutics, Inc. /DE/ annual Depreciation for 2022 was $30K.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $96K $26K +$7K +36.8% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-11
Q3 2024 $89K $25K +$6K +31.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $83K $23K +$8K +53.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $75K $22K +$8K +57.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $67K $19K Oct 1, 2023 Dec 31, 2023 10-K 2025-03-11
Q3 2023 $19K +$13K +217% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $15K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $14K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q3 2022 $6K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.